They showed an under-recognized mechanism that KRT6A acts downstream of LSD1 and upregulates G6PD through the MYC signaling pathway, demonstrating its vital role for NSCLC progression (47). This evidence concerns the gene KDM1A and non-small cell lung carcinoma.